Skip to main content

Syndication Analyzer vs. MRI Software

Institutional Depth Without the Institutional Price Tag

MRI Software is a $900M enterprise platform built for portfolio management across 170+ countries. You don't need a six-figure contract to model your syndication deals.

MRI Software is one of the largest real estate technology companies in the world, with $900M in revenue and 4,200+ employees. Their investment management module serves institutional fund managers, REITs, and large property owners. MRI does not offer a deal-level syndication underwriting tool — their platform operates at the enterprise portfolio level with pricing to match (six-to-seven figures annually). For a GP structuring individual syndication deals, MRI is massive overkill. Syndication Analyzer delivers the modeling depth GPs need at a price point that reflects deal-level value, not enterprise-level overhead.

Feature-by-Feature Comparison

See exactly where Syndication Analyzer and MRI Software differ.

FeatureSyndication AnalyzerMRI Software
Modeling
Deal-level waterfall modeling
Purpose-built for deal structuring
~Fund-level waterfalls only
Multi-class investor architecture
A/B/C class support
~Institutional fund classes
Multi-loan deal modeling
3 concurrent loans
~Treasury-level, not deal-level
Sponsor fee framework
All GP fee types
Not a focus area
Output
Live-formula Excel exports
Deal-team ready workbooks
~Institutional reporting
Deployment
Implementation time
Start modeling today
~6-12 month enterprise rollout
Focus
Target market
GP sponsors, family offices
~Institutional fund managers, REITs
Scope
Property scope
Multifamily syndication depth
~All CRE across 170+ countries
Pricing
Pricing
Starting at $97/month
~Six-to-seven figures annually
Context
Company size
Purpose-built startup
~$900M revenue, 4,200+ employees

Why GP Sponsors Choose Syndication Analyzer

Get deal-level syndication modeling without a six-figure annual contract

Start modeling deals today instead of waiting 6-12 months for enterprise implementation

Purpose-built for the GP structuring individual deals, not portfolio-level fund management

Avoid PE-driven price increases and product direction changes (MRI is exploring a $10B exit)

Same modeling depth for the syndication use case at 0.1% of the cost

Ready to Get Enterprise Depth, SaaS Pricing?

Join 100+ GP sponsors on the waitlist. Founding member pricing starts at $97/month.